Paul E. Freiman, President and CEO at NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ (NTII), bought 3,000 shares at $3.30 ($10K) on 2007-12-03, disclosed to the SEC on 2007-12-05.
Open-market purchase of $10k NTII by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| PPCO | SELL | 2008-06-12 | $15K | — | Filing → |
| PPCO | SELL | 2008-05-23 | $11K | — | Filing → |
| NTII | SELL | 2007-02-23 | $265K | — | Filing → |